Based on the in vitro findings that GIGYF2 promotes IR in hepatocytes through the STAU1/PTEN/AKT axis, we therefore further investigated whether GIGYF2 mediates obesity-induced IR in obese mice fed with HFD. Here, AKT1 is linked to obesity disorder.